Search Results 1771-1780 of 4117 for Solid

1. Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer - Mayo Clinic

   Measurable disease determined using guidelines of Response Evaluation Criteria In Solid Tumors (RECIST 1.1). Baseline tumor assessment should be performed ...

2. Treating pediatric patients with primary and recurrent rhabdomyosarcoma - Mayo Clinic

   Mayo Clinic's pediatric solid tumor team met with pediatric patient Riley Kane's oncologist virtually and used 3D modeling to plan his surgery. Dr. Granberg ...

3. Pembrolizumab in Treating Patients With Small Bowel Adenocarcinoma That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery - Mayo Clinic

   Willing and able to provide written informed consent for the trial; Measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST) 1.1; Had ...

4. A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) - Mayo Clinic

   Human immunodeficiency virus, hepatitis B virus, or hepatitis C virus positivity. History of solid organ transplantation; Known or suspected allergy or ...

5. A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread - Mayo Clinic

   ... Solid Tumors (RECIST 1.1); For Part G, H, and I: Have measureable disease as defined by RECIST 1.1. For all Parts except Part F and H: Participants must have ...

6. A Study of Idelalisib Combined with BI 836826 for Patients with Chronic Lymphocytic Leukemia - Mayo Clinic

   History of prior allogeneic bone marrow progenitor cell or solid organ transplantation; Ongoing systemic immunosuppressive therapy other than corticosteroids ...

7. Brightline-1: A Study to Compare Bi 907828 With Doxorubicin In People With a Type of Cancer Called Dedifferentiated Liposarcoma - Mayo Clinic

   retrospective histopathological central review. - Presence of at least one measurable target lesion according to Response Evaluation Criteria In Solid Tumors ( ...

8. Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia - Mayo Clinic

   Solid organ transplantation. 4. Subject has current diagnosis/usage of: 1. BMI greater than or equal to 40.0 kg/m2 2. Human Immunodeficiency Virus (HIV) 3 ...

9. Serial Blood And Urine Monitoring Study In Kidney Transplant Recipients - Mayo Clinic

   Recipient of previous non-renal solid organ and/or islet cell transplantation. Infection with HCV or HIV. Inability or unwillingness of a participant to ...

10. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

    CT scans or MRIs must be assessed and documented on the Baseline Tumor Assessment Form (Response Evaluation Criteria in Solid Tumors [RECIST] 1.1). Must have ...